HIF1α-siRNA and gemcitabine combination-based GE-11 peptide antibody-targeted nanomedicine for enhanced therapeutic efficacy in pancreatic cancers
出版年份 2018 全文链接
标题
HIF1α-siRNA and gemcitabine combination-based GE-11 peptide antibody-targeted nanomedicine for enhanced therapeutic efficacy in pancreatic cancers
作者
关键词
-
出版物
JOURNAL OF DRUG TARGETING
Volume -, Issue -, Pages 1-9
出版商
Informa UK Limited
发表日期
2018-11-28
DOI
10.1080/1061186x.2018.1552276
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Multimodal selenium nanoshell-capped Au@mSiO2 nanoplatform for NIR-responsive chemo-photothermal therapy against metastatic breast cancer
- (2018) Thiruganesh Ramasamy et al. NPG Asia Materials
- Smart chemistry-based nanosized drug delivery systems for systemic applications: A comprehensive review
- (2017) Thiruganesh Ramasamy et al. JOURNAL OF CONTROLLED RELEASE
- A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial†
- (2015) C. S. Fuchs et al. ANNALS OF ONCOLOGY
- Co-delivery of HIF1α siRNA and gemcitabine via biocompatible lipid-polymer hybrid nanoparticles for effective treatment of pancreatic cancer
- (2015) Xiao Zhao et al. BIOMATERIALS
- Systemic delivery of axitinib with nanohybrid liposomal nanoparticles inhibits hypoxic tumor growth
- (2015) Ju Yeon Choi et al. Journal of Materials Chemistry B
- Layer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugs
- (2014) Thiruganesh Ramasamy et al. Acta Biomaterialia
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer
- (2014) Lucas de Sousa Cavalcante et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation
- (2014) H.-Q. Ju et al. MOLECULAR CANCER THERAPEUTICS
- Codelivery of VEGF siRNA and Gemcitabine Monophosphate in a Single Nanoparticle Formulation for Effective Treatment of NSCLC
- (2013) Yuan Zhang et al. MOLECULAR THERAPY
- Role of epidermal growth factor receptor in breast cancer
- (2012) Hiroko Masuda et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Nanovector delivery of siRNA for cancer therapy
- (2012) H Shen et al. CANCER GENE THERAPY
- PolyIC GE11 polyplex inhibits EGFR-overexpressing tumors
- (2012) Galith Abourbeh et al. IUBMB LIFE
- Tuning Nanoparticle Uptake: Live-Cell Imaging Reveals Two Distinct Endocytosis Mechanisms Mediated by Natural and Artificial EGFR Targeting Ligand
- (2012) Frauke M. Mickler et al. NANO LETTERS
- EGF receptor-targeted nanocarriers for enhanced cancer treatment
- (2012) Alyssa M Master et al. Nanomedicine
- Gemcitabine-loaded innovative nanocarriers vs GEMZAR: Biodistribution, pharmacokinetic features andin vivoantitumor activity
- (2011) Christian Celia et al. Expert Opinion on Drug Delivery
- Disconnecting the Yin and Yang Relation of Epidermal Growth Factor Receptor (EGFR)-Mediated Delivery: A Fully Synthetic, EGFR-Targeted Gene Transfer System Avoiding Receptor Activation
- (2011) A. Schäfer et al. HUMAN GENE THERAPY
- Pancreatic cancer
- (2011) Audrey Vincent et al. LANCET
- siRNA delivery systems for cancer treatment
- (2009) Yu-Kyoung Oh et al. ADVANCED DRUG DELIVERY REVIEWS
- Novel Approaches to Deliver Gemcitabine to Cancers
- (2008) L. Reddy et al. CURRENT PHARMACEUTICAL DESIGN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now